The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Inhibition of Human Tyrosinase Requires Molecular Motifs Distinctively Different from Mushroom Tyrosinase
Open accessAbstract
Tyrosinase is the rate-limiting enzyme of melanin production and, accordingly, is the most prominent target for inhibiting hyperpigmentation. Numerous tyrosinase inhibitors have been identified, but most of those lack clinical efficacy because they were identified using mushroom tyrosinase as the target. Therefore, we used recombinant human tyrosinase to screen a library of 50,000 compounds and compared the active screening hits with well-known whitening ingredients. Hydroquinone and its derivative arbutin only weakly inhibited human tyrosinase with a half-maximal inhibitory concentration (IC 50 ) in the millimolar range, and kojic acid showed a weak efficacy (IC 50 > 500 μmol/L). The most potent inhibitors of human tyrosinase identified in this screen were resorcinyl-thiazole derivatives, especially the newly identified Thiamidol (Beiersdorf AG, Hamburg, Germany) (isobutylamido thiazolyl resorcinol), which had an IC 50 of 1.1 μmol/L. In contrast, Thiamidol only weakly inhibited mushroom tyrosinase (IC 50 = 108 μmol/L). In melanocyte cultures, Thiamidol strongly but reversibly inhibited melanin production (IC 50 = 0.9 μmol/L), whereas hydroquinone irreversibly inhibited melanogenesis (IC 50 = 16.3 μmol/L). Clinically, Thiamidol visibly reduced the appearance of age spots within 4 weeks, and after 12 weeks some age spots were indistinguishable from the normal adjacent skin. The full potential of Thiamidol to reduce hyperpigmentation of human skin needs to be explored in future studies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
UniProt: the Universal Protein knowledgebase
Apweiler, R. (2004) · Nucleic Acids Research · doi:10.1093/nar/gkh131 · Cited by 7,498
UniProt: the universal protein knowledgebase
The UniProt Consortium (2017) · Nucleic Acids Research · doi:10.1093/nar/gkw1099 · Cited by 4,436
An Updated Review of Tyrosinase Inhibitors
Chang, T.-S. (2009) · International Journal of Molecular Sciences · doi:10.3390/ijms10062440 · Cited by 1,552
Kim, Y.-J., & Uyama, H. (2005) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-005-5054-y · Cited by 1,062
Ismaya, W. T., Rozeboom, H. J., Weijn, A., Mes, J. J., Fusetti, F., Wichers, H. J., & Dijkstra, B. W. (2011) · Biochemistry · doi:10.1021/bi200395t · Cited by 872
Chemical and Instrumental Approaches to Treat Hyperpigmentation
Briganti, S., Camera, E., & Picardo, M. (2003) · Pigment Cell Research · doi:10.1034/j.1600-0749.2003.00029.x · Cited by 837
Matoba, Y., Kumagai, T., Yamamoto, A., Yoshitsu, H., & Sugiyama, M. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m509785200 · Cited by 792
Hypopigmenting agents: an updated review on biological, chemical and clinical aspects
Solano, F., Briganti, S., Picardo, M., & Ghanem, G. (2006) · Pigment Cell Research · doi:10.1111/j.1600-0749.2006.00334.x · Cited by 696
Ramsden, C. A., & Riley, P. A. (2014) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2014.02.048 · Cited by 368
Chalcones as potent tyrosinase inhibitors: the importance of a 2,4-substituted resorcinol moiety
Khatib, S., Nerya, O., Musa, R., Shmuel, M., Tamir, S., & Vaya, J. (2005) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2004.10.010 · Cited by 340
Mechanism of Depigmentation by Hydroquinone
Jimbow, K., Obata, H., Pathak, M. A., & Fitzpatrick, T. B. (1974) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12701679 · Cited by 323
Curto, E. V., Kwong, C., Hermersdörfer, H., Glatt, H., Santis, C., Virador, V., Hearing, V. J., & Dooley, T. P. (1999) · Biochemical Pharmacology · doi:10.1016/s0006-2952(98)00340-2 · Cited by 321
Self-citationFirst Structures of an Active Bacterial Tyrosinase Reveal Copper Plasticity
Sendovski, M., Kanteev, M., Ben-Yosef, V. S., Adir, N., & Fishman, A. (2011) · Journal of Molecular Biology · doi:10.1016/j.jmb.2010.10.048 · Cited by 299
Natural, semisynthetic and synthetic tyrosinase inhibitors
Lee, S. Y., Baek, N., & Nam, T.-G. (2016) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.3109/14756366.2015.1004058 · Cited by 293
Mechanism of inhibition of melanogenesis by hydroquinone
Palumbo, A., d'Ischia, M., Misuraca, G., & Prota, G. (1991) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/0304-4165(91)90186-k · Cited by 245
Lai, X., Wichers, H. J., Soler‐Lopez, M., & Dijkstra, B. W. (2017) · Angewandte Chemie International Edition · doi:10.1002/anie.201704616 · Cited by 235
Structure–function correlations in tyrosinases
Kanteev, M., Goldfeder, M., & Fishman, A. (2015) · Protein Science · doi:10.1002/pro.2734 · Cited by 229
Kinetic characterization of the substrate specificity and mechanism of mushroom tyrosinase
Espín, J. C., Varón, R., Fenoll, L. G., Gilabert, M. A., García‐Ruíz, P. A., Tudela, J., & García‐Cánovas, F. (2000) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2000.01013.x · Cited by 227
Final Report of the Safety Assessment of Kojic Acid as Used in Cosmetics
Burnett, C. L., Bergfeld, W. F., Belsito, D. V., Hill, R. A., Klaassen, C. D., Liebler, D. C., Marks, J. G., Shank, R. C., Slaga, T. J., Snyder, P. W., et al. (2010) · International Journal of Toxicology · doi:10.1177/1091581810385956 · Cited by 182
Kolbe, L., Mann, T., Gerwat, W., Batzer, J., Ahlheit, S., Scherner, C., Wenck, H., & Stäb, F. (2013) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.12051 · Cited by 173
Self-citationTyrosinase Inhibition: General and Applied Aspects
Rescigno, A., Sollai, F., Pisu, B., Rinaldi, A., & Sanjust, E. (2002) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.1080/14756360210000010923 · Cited by 162
Mutational mapping of the catalytic activities of human tyrosinase.
Tripathi, R. K., Hearing, V. J., Urabe, K., Aroca, P., & Spritz, R. A. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)35895-2 · Cited by 141
Self-citationSasaki, M., Kondo, M., Sato, K., Umeda, M., Kawabata, K., Takahashi, Y., Suzuki, T., Matsunaga, K., & Inoue, S. (2014) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.12269 · Cited by 130
Heterologous expression and characterization of functional mushroom tyrosinase (AbPPO4)
Pretzler, M., Bijelic, A., & Rompel, A. (2017) · Scientific Reports · doi:10.1038/s41598-017-01813-1 · Cited by 116
Olivares, C., García-Borrón, J. C., & Solano, F. (2001) · Biochemistry · doi:10.1021/bi011535n · Cited by 109
Tyrosinase related protein 1 (TYRP1/gp75) in human cutaneous melanoma
Ghanem, G., & Journé, F. (2011) · Molecular Oncology · doi:10.1016/j.molonc.2011.01.006 · Cited by 106
Jin, Y. H., Lee, S. J., Chung, M. H., Park, J. H., Park, Y. I., Cho, T. H., & Lee, S. K. (1999) · Archives of Pharmacal Research · doi:10.1007/bf02976355 · Cited by 102
Mushroom Tyrosinase: Catalase Activity, Inhibition, and Suicide Inactivation
Garcı́a-Molina, F., Hiner, A. N. P., Fenoll, L. G., Rodríguez‐López, J. N., Garcı́a-Ruiz, P. A., Garcı́a-Cánovas, F., & Tudela, J. (2005) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf048340h · Cited by 89
Mammalin tyrosinase. Stoichiometry and measurement of reaction products
Hearing, V. J., Ekel, T. M., Montague, P., & Nicholson, J. M. (1980) · Biochimica et Biophysica Acta (BBA) - Enzymology · doi:10.1016/0005-2744(80)90061-3 · Cited by 85
Self-citationAction of tyrosinase on alpha and beta-arbutin: A kinetic study
Garcia-Jimenez, A., Teruel, J. A., Berná, J., Rodríguez‐López, J. N., Tudela, J., & García-Cánovas, F. (2017) · PLoS ONE · doi:10.1371/journal.pone.0177330 · Cited by 84
Short-Sequence Oligopeptides with Inhibitory Activity against Mushroom and Human Tyrosinase
Ubeid, A. A., Zhao, L., Wang, Y., & Hantash, B. M. (2009) · Journal of Investigative Dermatology · doi:10.1038/jid.2009.124 · Cited by 77
Lai, X., Soler‐López, M., Wichers, H. J., & Dijkstra, B. W. (2016) · PLoS ONE · doi:10.1371/journal.pone.0161697 · Cited by 77
Syntheses of α-arbutin-α-glycosides and their inhibitory effects on human tyrosinase
Sugimoto, K., Nomura, K., Nishimura, T., Kiso, T., Sugimoto, K., & Kuriki, T. (2005) · Journal of Bioscience and Bioengineering · doi:10.1263/jbb.99.272 · Cited by 75
Ito, S., Ojika, M., Yamashita, T., & Wakamatsu, K. (2014) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.12275 · Cited by 72
Optimal Management of Recalcitrant Disorders of Hyperpigmentation in Dark-Skinned Patients
Stratigos, A., & Katsambas, A. (2004) · American Journal of Clinical Dermatology · doi:10.2165/00128071-200405030-00004 · Cited by 66
Ito, S., & Wakamatsu, K. (2015) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2015.07.007 · Cited by 62
Fogal, S., Carotti, M., Giaretta, L., Lanciai, F., Nogara, L., Bubacco, L., & Bergantino, E. (2014) · Molecular Biotechnology · doi:10.1007/s12033-014-9800-y · Cited by 61
Topical Hypopigmenting Agents for Pigmentary Disorders and Their Mechanisms of Action
Kim, H., Choi, H.-R., Kim, D.-S., & Park, K. (2012) · Annals of Dermatology · doi:10.5021/ad.2012.24.1.1 · Cited by 57
Chen, Q., Ke, L., Song, K., Huang, H., & Liu, X. (2004) · The Protein Journal · doi:10.1023/b:jopc.0000020080.21417.ff · Cited by 52
Schweikardt, T., Olivares, C., Solano, F., Jaenicke, E., García-Borrón, J. C., & Decker, H. (2007) · Pigment Cell Research · doi:10.1111/j.1600-0749.2007.00405.x · Cited by 48
Nesterov, A., Zhao, J., Minter, D. E., Hertel, C., Ma, W., Abeysinghe, P., Hong, M., & Jia, Q. (2008) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.56.1292 · Cited by 45
Human tyrosinase is able to oxidize both enantiomers of rhododendrol
Ito, S., Gerwat, W., Kolbe, L., Yamashita, T., Ojika, M., & Wakamatsu, K. (2014) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.12300 · Cited by 41
Self-citation4‐(1‐Phenylethyl)1,3‐Benzenediol: A New, Highly Efficient Lightening Agent
Vielhaber, G., Schmaus, G., Jacobs, K., et al. (2007) · International Journal of Cosmetic Science · doi:10.1111/j.1467-2494.2007.00355_6.x · Cited by 38
Characterization of the action of tyrosinase on resorcinols
Garcia-Jimenez, A., Teruel, J. A., Berná, J., Rodríguez‐López, J. N., Tudela, J., García-Ruiz, P. A., & García-Cánovas, F. (2016) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2016.07.048 · Cited by 31
Inhibitory Action of 4-n-Butylresorcinol (Rucinol) on Melanogenesis and Its Skin Whitening Effects.
Katagiri, T., Okubo, T., Oyobikawa, M., Futaki, K., Shaku, M., Kawai, M., & Takenouchi, M. (2001) · Journal of Society of Cosmetic Chemists of Japan · doi:10.5107/sccj.35.42 · Cited by 14
On the interpretation of tyrosinase inhibition kinetics
Sun, W., Wendt, M., Klebe, G., & Röhm, K. (2013) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.3109/14756366.2012.755621 · Cited by 13
Self-citation
Cited by
A comprehensive review on tyrosinase inhibitors
Zolghadri, S., Bahrami, A., Hassan Khan, M. T., Munoz-Munoz, J., Garcia-Molina, F., Garcia-Canovas, F., & Saboury, A. A. (2019) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.1080/14756366.2018.1545767 · Cited by 1,078
Del Bino, S., Duval, C., & Bernerd, F. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19092668 · Cited by 315
Boo, Y. C. (2019) · Antioxidants · doi:10.3390/antiox8080275 · Cited by 267
Liu, J.-K. (2022) · Natural Products and Bioprospecting · doi:10.1007/s13659-022-00363-y · Cited by 263
Panzella, L., & Napolitano, A. (2019) · Cosmetics · doi:10.3390/cosmetics6040057 · Cited by 208
Metadata
- Authors
- Mann, T., Gerwat, W., Batzer, J., Eggers, K., Scherner, C., Wenck, H., Stäb, F., Hearing, V. J., Röhm, K.-H., & Kolbe, L.
- Venue
- Journal of Investigative Dermatology
- Publisher
- Elsevier BV
- Published
- 2018-07
- Volume
- 138
- Issue
- 7
- Pages
- 1601-1608
- ISSN
- 0022-202X (ISSN-L)
- OpenAlex
- W2786693416
- Cited by
- 259
- References
- 46
- FWCI
- 8.08
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.